Figure J. Decreased Susceptibility to Cefixime Among GISP Isolates, 1992-2006
This web page is archived for historical purposes and is no longer being updated. Newer data is available on the STD Data and Statistics page.
CLINIC | % of isolates | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1992 | 1993 | 1994 | 1995 | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | |
ALBUQUERQUE | . | . | 0.6 | . | . | . | . | . | . | . | . | . | . | . | . |
ATLANTA | 0.4 | . | . | . | . | . | . | . | . | . | . | . | . | . | . |
BALTIMORE | . | . | . | . | . | . | . | . | . | . | . | . | . | . | . |
BIRMINGHAM | . | . | 0.4 | . | . | . | . | . | . | . | . | . | . | . | . |
CHICAGO | . | . | . | . | . | . | . | . | . | . | . | . | . | . | . |
CINCINNATI | 0.8 | 0.8 | . | . | . | 0.5 | . | . | . | . | . | . | . | . | . |
CLEVELAND | . | . | . | . | . | . | . | . | . | . | . | . | . | . | . |
DALLAS | . | . | . | . | . | . | . | . | . | . | . | . | . | . | . |
DENVER | . | . | 0.4 | . | . | . | . | . | . | . | . | . | . | . | . |
DETROIT | . | . | . | . | . | . | . | . | . | . | . | . | . | . | . |
GREENSBORO | . | . | . | . | . | . | . | . | . | . | . | . | . | . | . |
HONOLULU | . | . | . | . | . | . | . | . | . | 3.8 | . | . | . | . | . |
KANSAS CITY | . | . | . | . | . | . | . | . | . | . | . | . | . | . | . |
LAS VEGAS | . | . | . | . | . | . | . | . | . | . | . | . | . | . | . |
LOS ANGELES | . | . | . | . | . | . | . | . | . | . | . | . | 0.7 | . | 0.5 |
MIAMI | . | . | . | . | . | . | . | . | . | . | . | . | . | . | . |
MINNEAPOLIS | . | . | . | . | . | . | . | . | . | . | . | . | . | . | . |
NEW ORLEANS | 0.5 | . | . | . | . | . | . | . | . | . | . | . | . | . | . |
NEW YORK CITY | . | . | . | . | . | . | . | . | . | . | . | . | . | . | . |
OKLAHOMA CITY | . | . | . | . | . | . | . | . | . | . | . | . | . | . | . |
ORANGE COUNTY | . | 0.9 | . | 0.7 | . | . | . | . | . | . | . | . | . | . | . |
PHILADELPHIA | 1.3 | . | . | . | . | 1.3 | 1.3 | . | . | . | . | . | . | . | . |
PHOENIX | 0.4 | 0.8 | . | 1.3 | . | . | . | . | . | 0.4 | . | . | . | . | . |
PORTLAND | . | . | . | . | . | . | . | . | . | . | . | . | . | . | . |
SAN DIEGO | 0.9 | . | . | 0.4 | . | . | . | . | . | . | . | . | . | . | . |
SAN FRANCISCO | . | . | . | . | . | . | . | . | . | . | . | . | . | . | . |
SEATTLE | . | . | . | . | . | . | . | . | . | . | . | . | . | . | . |
Susceptibility testing for cefixime was discontinued in 2007 and 2008.
- Page last reviewed: May 17, 2010 (archived document)
- Content source: